The Lancet Rheumatology

1. Lancet Rheumatol12 Nov 2025

   Pan American League of Associations for Rheumatology recommendations for the management of rheumatoid arthritis

   Guideline or statementRA

2. Lancet Rheumatol3 Nov 2025

   IgG4-related disease in the Japanese population: a whole-genome sequencing study

   Case-control studyAutoinflammatory & rare

3. Lancet Rheumatol28 Oct 2025

   Fetal and maternal outcome in the pregnancies of patients with systemic sclerosis and very early diagnosis of systemic sclerosis in France: a prospective study

   Cohort studySystemic sclerosis

4. Lancet Rheumatol17 Oct 2025

   Pregnancy outcomes in patients with systemic vasculitis in the USA from 2007 to 2022: an administrative claims-based study

   Cohort studyVasculitis & PMR

5. Lancet Rheumatol15 Oct 2025

   Skeletal muscle effects of Janus kinase inhibition in rheumatoid arthritis (RAMUS): a single-arm, experimental medicine study

   Cohort studyRA

6. Lancet Rheumatol14 Oct 2025

   Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: a cross-sectional analysis of the prospective SAIL-RA cohort in the USA

   Cross-sectional studyRA

7. Lancet Rheumatol29 Sep 2025

   Machine learning to classify the focus score and Sjögren's disease using digitalised salivary gland biopsies: a retrospective cohort study

   Cohort studySjögren's & overlap

8. Lancet Rheumatol17 Sep 2025

   Patient outcomes from implementing a shared decision-making aid for systemic lupus erythematosus: a prospective implementation study

   Cohort studyLupus & APS

9. Lancet Rheumatol16 Sep 2025

   The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021

   Meta-analysisOsteoporosis

10. Lancet Rheumatol4 Sep 2025

    Mapping the infectious burden in VEXAS syndrome: a systematic review and rationale for prevention

    Meta-analysisAutoinflammatory & rare

11. Lancet Rheumatol4 Sep 2025

    Development and validation of a prognostic model for predicting the risk of allopurinol-induced severe cutaneous adverse reactions: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data

    Cohort studyGout & crystals

12. Lancet Rheumatol4 Sep 2025

    Serum biomarkers associated with baricitinib response in patients with juvenile idiopathic arthritis: a post-hoc analysis of the phase 3 JUVE-BASIS trial

    Secondary analysisPediatric

13. Lancet Rheumatol3 Sep 2025

    Effect of a treatment strategy utilising golimumab, methotrexate and corticosteroids versus methotrexate and corticosteroids in early, untreated psoriatic arthritis (GOLMePsA): a single-centre, double-blind, parallel-group, randomised controlled trial

    Randomized controlled trialSpondyloarthritis & PsA

14. Lancet Rheumatol12 Aug 2025

    Personalised gait retraining for medial compartment knee osteoarthritis: a randomised controlled trial

    Randomized controlled trialOsteoarthritis

15. Lancet Rheumatol6 Aug 2025

    Cognitive functional therapy with or without movement sensor biofeedback versus usual care for chronic, disabling low back pain (RESTORE): 3-year follow-up of a randomised, controlled trial

    Secondary analysisFibromyalgia & pain

16. Lancet Rheumatol31 Jul 2025

    Clinical and cost-effectiveness of a cycling and education intervention versus usual physiotherapy care for the treatment of hip osteoarthritis in the UK (CLEAT): a pragmatic, randomised, controlled trial

    Randomized controlled trialOsteoarthritis

17. Lancet Rheumatol29 Jul 2025

    Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial

    Randomized controlled trialRA

18. Lancet Rheumatol24 Jul 2025

    Effectiveness of treat-to-target tapering of TNF inhibitors for psoriatic arthritis and axial spondyloarthritis in the Netherlands: 24-month follow-up of the DRESS-PS trial

    Randomized controlled trialSpondyloarthritis & PsA

19. Lancet Rheumatol23 Jun 2025

    Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 study

    Randomized controlled trialRA

20. Lancet Rheumatol19 Jun 2025

    Sarilumab in relapsing polymyalgia rheumatica: patient-reported outcomes from a phase 3, double-blind, randomised controlled trial

    Secondary analysisVasculitis & PMR

21. Lancet Rheumatol13 Jun 2025

    Comparison of findings on contrast-enhanced MRI of the hand, wrist, and forefoot in healthy controls, two at-risk groups, and patients with rheumatoid arthritis: a cohort study

    Cohort studyRA

22. Lancet Rheumatol11 Jun 2025

    Dual JAK and ROCK inhibition with CPL'116 in patients with rheumatoid arthritis with inadequate response to methotrexate: a randomised, double-blind, placebo-controlled, phase 2 trial

    Randomized controlled trialRA

23. Lancet Rheumatol11 Jun 2025

    Exposure to hydroxychloroquine in early pregnancy and incidence of pre-eclampsia and pre-term delivery in patients with systemic lupus erythematosus in Sweden: a nationwide population-based cohort study

    Cohort studyLupus & APS

24. Lancet Rheumatol10 Jun 2025

    Whole-body MRI in patients with arthralgia or inflammatory arthritis after exposure to immune checkpoint inhibitors: a single-centre prospective imaging study

    Cohort studyAcross diseases

25. Lancet Rheumatol10 Jun 2025

    Occupational therapist-led versus rheumatologist-led care in people with hand osteoarthritis in Norway: an open-label, multicentre, randomised controlled, non-inferiority trial

    Randomized controlled trialOsteoarthritis

26. Lancet Rheumatol2 Jun 2025

    Trends in the prevalence of autoimmune diseases during pregnancy in the UK, 2000–21: a retrospective cohort study

    Cohort studyAcross diseases

27. Lancet Rheumatol28 May 2025

    Long-term effectiveness of non-surgical interventions for chronic low back pain: a systematic review and meta-analysis

    Meta-analysisFibromyalgia & pain

28. Lancet Rheumatol23 May 2025

    ERN ReCONNET–SLICC–SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations

    Guideline or statementLupus & APS

29. Lancet Rheumatol21 May 2025

    Treatment outcomes in patients with VEXAS syndrome: a retrospective cohort study

    Cohort studyAutoinflammatory & rare

30. Lancet Rheumatol21 May 2025

    Maternal autoantibodies to the sodium potassium pump α1 subunit AT1A1 and fetal autoimmune congenital heart block: a case-control study

    Case-control studyLupus & APS

31. Lancet Rheumatol14 May 2025

    Predicting the risk of subsequent progression in patients with systemic sclerosis-associated interstitial lung disease with progression: a multicentre observational cohort study

    Cohort studySystemic sclerosis

32. Lancet Rheumatol2 May 2025

    Long-term effect of anifrolumab on patient-reported outcomes in systemic lupus erythematosus (TULIP-LTE): a randomised, placebo-controlled, phase 3 long-term extension trial

    Randomized controlled trialLupus & APS

33. Lancet Rheumatol30 Apr 2025

    Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study

    Cohort studyLupus & APS

34. Lancet Rheumatol31 Mar 2025

    Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study

    Cohort studySystemic sclerosis

35. Lancet Rheumatol8 Mar 2025

    Diagnostic, research, and real-life effect of the 2023 EULAR−ACR classification criteria for antiphospholipid syndrome

    Research articleLupus & APS

36. Lancet Rheumatol27 Feb 2025

    Clinical manifestations, disease penetrance, and treatment in individuals with SOCS1 insufficiency: a registry-based and population-based study

    Cohort studyAutoinflammatory & rare

37. Lancet Rheumatol18 Feb 2025

    The effect of ixekizumab treatment on MRI sacroiliac joint structural lesions in patients with radiographic axial spondyloarthritis: post-hoc analysis of a 52-week, randomised, placebo-controlled trial with an active reference arm

    Secondary analysisSpondyloarthritis & PsA

38. Lancet Rheumatol5 Feb 2025

    Addition of aerobic physical activity to resistance exercise for hip osteoarthritis (PHOENIX): a randomised comparative effectiveness trial

    Randomized controlled trialOsteoarthritis

39. Lancet Rheumatol3 Feb 2025

    Survival in patients with rheumatoid arthritis and recently diagnosed early-stage colorectal, lung, or prostate cancer receiving tumour necrosis factor inhibitors: a retrospective cohort study

    Cohort studyRA

40. Lancet Rheumatol31 Jan 2025

    Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trial

    Randomized controlled trialSystemic sclerosis

All 184 Briefs in ExploreShowing Briefs 41–80 of 184, newest first